#geriatry — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #geriatry, aggregated by home.social.
-
just how true is that 👀 :blobcatgoogly:
"We have to find sources of #entropy
How many older people you know tell the same stories and jokes over and over? Watch the same shows. Listen to the same five bands, and then eventually two. Our aperture slowly shrinks until we die."
-
just how true is that 👀 :blobcatgoogly:
"We have to find sources of #entropy
How many older people you know tell the same stories and jokes over and over? Watch the same shows. Listen to the same five bands, and then eventually two. Our aperture slowly shrinks until we die."
-
just how true is that 👀 :blobcatgoogly:
"We have to find sources of #entropy
How many older people you know tell the same stories and jokes over and over? Watch the same shows. Listen to the same five bands, and then eventually two. Our aperture slowly shrinks until we die."
-
just how true is that 👀 :blobcatgoogly:
"We have to find sources of #entropy
How many older people you know tell the same stories and jokes over and over? Watch the same shows. Listen to the same five bands, and then eventually two. Our aperture slowly shrinks until we die."
-
just how true is that 👀 :blobcatgoogly:
"We have to find sources of #entropy
How many older people you know tell the same stories and jokes over and over? Watch the same shows. Listen to the same five bands, and then eventually two. Our aperture slowly shrinks until we die."
-
🧪
#Geriatry
Voici la présentation du projet d'avis commun des 2 Académies royales de Médecine de Belgique et les conclusions des workshops sur la santé mentale et le bien-être des personnes âgées par Pr Éric Constant & Pr Mirko Pétrovic:
youtu.be/ulXE3at5VTU
youtu.be/Lx0ZeBB7SDc -
@macesari Interesting, to say the least. Fine, if geriatricians educate themselves about the neurological and pharmacological intricacies of AD (which begins maybe two decades before any symptoms), but very many memory patients meet a geriatrician way too late. I haven't met one thus far, and was a guinea-pig in aducanumab-research for 4 years (got it 10 mg/kg). From my own experience and what I have studied during the journey, I concur with the minimal clinical advantage and the heavy burden of monthly infusions. But it is quite another question, who should lead the patience care at MCI-level and before, where MAB's can still make a difference.
-
@macesari Interesting, to say the least. Fine, if geriatricians educate themselves about the neurological and pharmacological intricacies of AD (which begins maybe two decades before any symptoms), but very many memory patients meet a geriatrician way too late. I haven't met one thus far, and was a guinea-pig in aducanumab-research for 4 years (got it 10 mg/kg). From my own experience and what I have studied during the journey, I concur with the minimal clinical advantage and the heavy burden of monthly infusions. But it is quite another question, who should lead the patience care at MCI-level and before, where MAB's can still make a difference.
-
@macesari Interesting, to say the least. Fine, if geriatricians educate themselves about the neurological and pharmacological intricacies of AD (which begins maybe two decades before any symptoms), but very many memory patients meet a geriatrician way too late. I haven't met one thus far, and was a guinea-pig in aducanumab-research for 4 years (got it 10 mg/kg). From my own experience and what I have studied during the journey, I concur with the minimal clinical advantage and the heavy burden of monthly infusions. But it is quite another question, who should lead the patience care at MCI-level and before, where MAB's can still make a difference.
-
@macesari Interesting, to say the least. Fine, if geriatricians educate themselves about the neurological and pharmacological intricacies of AD (which begins maybe two decades before any symptoms), but very many memory patients meet a geriatrician way too late. I haven't met one thus far, and was a guinea-pig in aducanumab-research for 4 years (got it 10 mg/kg). From my own experience and what I have studied during the journey, I concur with the minimal clinical advantage and the heavy burden of monthly infusions. But it is quite another question, who should lead the patience care at MCI-level and before, where MAB's can still make a difference.